Literature DB >> 8904520

Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease.

E Grottrup-Wolfers1, J Moeller, U Karbach, S Muller-Lissner, S Endres.   

Abstract

The aim of this study was to investigate the involvement of the monocyte-derived cytokines interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) in idiopathic inflammatory bowel disease. Endoscopic biopsies of normal and inflamed intestinal mucosa were obtained from patients with ulcerative colitis (n = 11) and with Crohn's disease (n = 10). Intestinal mucosal cells were isolated by collagenase digestion. Cell viability, morphology and CD14 expression were determined. To measure cell-associated cytokine levels, cells were lysed and analysed for IL-1beta and TNF-alpha in specific radioimmunoassays and for IL-6 using a biological assay. Compared with mucosal cells from control patients without inflammatory bowel disease the inflamed intestine in ulcerative colitis and Crohn's disease displayed markedly enhanced levels of IL-1beta (median 245 pg 10(-6) cells, range 30-1275) and IL-6 (median 22 U 10(-6) cells, range 1-298). Non-inflamed mucosa in patients with ulcerative colitis and Crohn's disease did not show elevated levels of IL-1beta (median 50 pg 10(-6) cells, range 33-90) or IL-6 (mean below detection limit of assay, i.e. 1 U 10(-6) cells). In contrast, no clear cut difference between inflamed and non-inflamed mucosa could be detected for TNF-alpha. High tissue levels of IL-6 were associated with a high endoscopic grade of local inflammation. These results suggest that the monocyte-derived cytokines IL-1beta and IL-6 are mediators of inflammation in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904520     DOI: 10.1046/j.1365-2362.1996.123262.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

2.  Constitutive androstane receptor regulates the intestinal mucosal response to injury.

Authors:  Grace M Hudson; Kyle L Flannigan; Sarah L Erickson; Fernando A Vicentini; Alexandra Zamponi; Christina L Hirota; Laurie Alston; Christophe Altier; Subrata Ghosh; Kevin P Rioux; Sridhar Mani; Thomas K Chang; Simon A Hirota
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

3.  Differential expression and upregulation of interleukin-1alpha, interleukin-1beta and interleukin-6 by freshly isolated human small intestinal epithelial cells.

Authors:  Laura Madrigal-Estebas; Derek G Doherty; Diarmuid P O'Donoghue; Conleth Feighery; Cliona O'Farrelly
Journal:  Mediators Inflamm       Date:  2002-10       Impact factor: 4.711

4.  Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.

Authors:  Edmond K Ng; Ninder Panesar; Walter E Longo; Marc J Shapiro; Donald L Kaminski; Kym C Tolman; John E Mazuski
Journal:  Mediators Inflamm       Date:  2003-02       Impact factor: 4.711

5.  Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties.

Authors:  Alexander A Chumanevich; Erin E Witalison; Anusha Chaparala; Anastasiya Chumanevich; Prakash Nagarkatti; Mitzi Nagarkatti; Lorne J Hofseth
Journal:  Oncotarget       Date:  2016-08-16

6.  Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Kacper Nijakowski; Anna Surdacka
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

7.  Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.

Authors:  Priyatharsan Yoganathan; Jean-Benoit Rossel; Sebastian Bruno Ulrich Jordi; Yannick Franc; Luc Biedermann; Benjamin Misselwitz; Martin Hausmann; Gerhard Rogler; Michael Scharl; Isabelle Frey-Wagner
Journal:  BMC Gastroenterol       Date:  2021-08-03       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.